Toxic solvent residues DMF (dimethylformamide) Known liver toxin Associated with reproductive toxicity Must be removed to extremely low limits in GMP drugs DCM (dichloromethane / methylene chloride) Probable human carcinogen Central nervous system depressant Dangerous even in small amounts if injected TFA (trifluoroacetic acid) Corrosive Can remain in peptides as unmeasured TFA salt Pharmaceutical products often convert TFA salts to safer counterions Without validated HPLC, mass spectrometry, and residual solvent testing, patients may be injected with harmful chemical contaminants
Most reactions are mild to moderate, but you should expect some level of joint or muscle discomfort especially in the first weeks
In locally advanced (stage III) NSCLC, most fit patients receive concurrent chemotherapy with a platinum-doublet and RT (CCRT), followed by one year of durvalumab (anti-PD-L1) therapy [3]
During the early healing phase, fibroblasts produce mainly Type III collagen to form the first repair tissue
Simple, effective, and ready to fuel the day